Medifast (MED)
Medifast Liabilities: 39.16M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
MED Liabilities Rankings
| Overall | 81st percentile | 827 of 4390 |
| Sector | 87th percentile | 109 of 852 in Services |
| Industry | 84th percentile | 5 of 32 in Specialty Retail, Other |
MED Liabilities Range, Past 5 Years
| Minimum | 8.981M | Sep 2007 |
| Maximum | 39.16M | Mar 2012 |
| Average | 18.91M |
About Total Liabilities
Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.
Total liabilities is a line item on the balance sheet.
Learn More
You may also be interested in these MED related companies
MED News
$MED purchased 150,000 shares of its common this week at cost basis of $18.34 http://stks.co/3zoW
about 5 days ago by WallStreetBean
about 5 days ago by WallStreetBean
$VVUS still long 2/3 sadly wt loss & diabetes drugs a growth industry. watch techncls for timing tho. $HLF $WTW $MED are done imho,
about 18 days ago by TrendHunter
about 18 days ago by TrendHunter
$HLF $WTW should get more down pressure with $ARNA approval imho. These remain as shorts. $MED is an oddity, perhaps just a short sqz
about 20 days ago by TrendHunter
about 20 days ago by TrendHunter
Auriga Reiterates a 'Buy' on Medifast (MED); Still Like Long-Term, But Cutting Estimates on Mixed Results
May 09, 10:47AM Street Insider
May 09, 10:47AM Street Insider
Mercadolibre, Gulfport Energy Corporation Among Stocks Gapping Down Wednesday
May 09, 10:31AM Fox Business
May 09, 10:31AM Fox Business
$MED is 6.1% up since open on unusual high volume but still -7.6% down since close.
about 22 days ago by TradeBot
about 22 days ago by TradeBot
$MED 200 Day SMA Cross - Price crossed below 200 day SMA (16.4047). Confirmed by volume.
about 22 days ago by TradeIdeasQuant
about 22 days ago by TradeIdeasQuant
Listen to $MED Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3jHT
about 22 days ago by earningscast
about 22 days ago by earningscast
$MED i will risk it. With new MGM i believe that might want to prove something as well. Odds seem good.
about 23 days ago by nobr3ga
about 23 days ago by nobr3ga
@nobr3ga $MED fundies look really good to me going into EPS, but....will they look good coming out? That's the ?
about 23 days ago by WallStreetBean
about 23 days ago by WallStreetBean
@WallStreetBean $MED has a good 50% retracement. $HLF had a great Q, but were pyramid scheme operations. With regards to $WTW I dnt know
about 23 days ago by nobr3ga
about 23 days ago by nobr3ga
@nobr3ga been long $MED for a while but feeling a bit squeamish in light of recent Q's from $HLF and $WTW. Maybe they will break trend.
about 23 days ago by WallStreetBean
about 23 days ago by WallStreetBean
Competitor $MED reports 5/8. Keep Einhorn away! RT @harmongreg It may be time to give Herb a new Life, if you know what I mean $$
about 25 days ago by WallStreetBean
about 25 days ago by WallStreetBean
$HLF $WTW $MED seems like trading community thinks drugs $VVUS etc are the wt loss future. The American way, dont have self cntrl use drugs.
about 28 days ago by TrendHunter
about 28 days ago by TrendHunter
Surprised $MED held up as well as it did today after $HLF's punishment.
about 29 days ago by WallStreetBean
about 29 days ago by WallStreetBean
Medifast, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2012
Apr 24, 4:05PM PR Newswire
Apr 24, 4:05PM PR Newswire
$MED more than 20% float is short with about 12 days to cover. Bloodsport.
about 43 days ago by WallStreetBean
about 43 days ago by WallStreetBean
Medifast continues to make investors fat. $MED number 10 overall today. Great Chart.
about 44 days ago by billgunderson
about 44 days ago by billgunderson
Canaccord Genuity Maintains a 'Buy' on Medifast (MED); Limited Downside, But Waiting For Clarity To Upside
Apr 10, 9:51AM Street Insider
Apr 10, 9:51AM Street Insider
don't know why but not complaining. RT @bricktop13 $MED breaking out of an 8-month base.
about 59 days ago by WallStreetBean
about 59 days ago by WallStreetBean
Auriga Reiterates a 'Buy' on Medifast (MED), but Cutting Numbers on Growing Pains
Mar 14, 1:47PM Street Insider
Mar 14, 1:47PM Street Insider
Wedbush Maintains an 'Outperform' on Medifast (MED); Mixed Q4; Raising Estimates on Accelerating Outlook
Mar 14, 1:17PM Street Insider
Mar 14, 1:17PM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| MED | 18.07 | -0.79 | -4.19% | 280.27M |
| MEAS | 32.91 | -0.63 | -1.88% | 503.77M |
| MEAD | 3.54 | +0.00 | +0.00% | 4.354M |
| MAXY | 5.81 | -0.06 | -1.02% | 163.01M |
| MAV | 15.16 | +0.00 | +0.00% | |
| MATW | 29.98 | -0.49 | -1.61% | 864.43M |
| MATR | 6.93 | -0.06 | -0.86% | 117.29M |
| MAT | 31.17 | -0.34 | -1.08% | 10.68B |
| MASC | 8.05 | -0.05 | -0.62% | 85.37M |
| MAS | 12.36 | -0.64 | -4.92% | 4.645B |